<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsFei Su, Jeffrey A. Sosman, Xiangju Kong et al.|New England Journal of Medicine|2012Cited by 1k
Identification of a Disease-Defining Gene Fusion in Epithelioid HemangioendotheliomaMunir R. Tanas, Brian P. Rubin, Andrea Sboner et al.|Science Translational Medicine|2011Cited by 401
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working GroupM.F. Mosele, Fabrice André, C. Benedikt Westphalen et al.|Annals of Oncology|2024Cited by 343
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP. Tarantino, G. Curigliano, Giulia Viale et al.|Annals of Oncology|2023Cited by 298
Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular DiversityVanessa Almendro, Kornélia Polyák, Yu-Kang Cheng et al.|Cell Reports|2014Cited by 283